INDP

Indaptus Therapeutics Inc

• TipRanks·04/03 16:30

  Indaptus Therapeutics Names New CFO, Refreshes Board Oversight

• Reuters·04/03 16:01

  INDAPTUS THERAPEUTICS INC - APPOINTS YU DING AS CFO EFFECTIVE APRIL 1, 2026 - SEC FILING

• Reuters·04/03 16:00

  Indaptus Therapeutics names Yu Ding CFO after Nir Sassi resignation

• Reuters·04/02 23:19

  Indaptus Therapeutics files Form 3 initial beneficial ownership statement for Yun Yao

• Reuters·04/02 23:17

  Indaptus Therapeutics files Form 3; Sino Lion Ventures reports beneficial ownership

• Reuters·04/02 23:16

  Indaptus Therapeutics files Form 3 for CEO Junyi Dai initial beneficial ownership statement

• Reuters·03/26 18:10

  Indaptus Therapeutics FY2025 annual report published; net loss widens to $21 million

• TipRanks·03/24 21:09

  Indaptus Therapeutics Announces Major Leadership and Board Changes

• Reuters·03/24 20:31

  Indaptus investors group discloses 96.2% beneficial ownership after preferred conversion

• Benzinga·03/03 12:05

  12 Health Care Stocks Moving In Tuesday's Pre-Market Session

• TipRanks·02/27 21:40

  Indaptus Shareholders Approve Major Charter and Capital Changes

• Reuters·02/27 21:09

  Indaptus Therapeutics Wins Approval for Reverse Stock Split Authority

• Reuters·02/27 21:06

  Indaptus Therapeutics Inc. Files Initial Beneficial Ownership Statement for Director Jerome D. Jabbour

• Reuters·02/26 15:57

  Indaptus Therapeutics Director Matthew Charles McMurdo Files Initial Statement of Beneficial Ownership (Form 3)

• TipRanks·02/12 14:57

  Indaptus Therapeutics Reprices Warrants to Bolster Shareholder Support